Skip to main content
. 2024 Nov 4;4:207. Originally published 2024 Sep 23. [Version 2] doi: 10.12688/openreseurope.18008.2

Table 6. Recommendations for policy makers.

Recommendations for policy makers Prompt benefits
To expand the application of sustainable practices to all contributors to the supply chain of research materials and goods (e.g., transporting, packaging, producing, distributing). Globalization of norms to favour good practices in research for PVBD of humans and animals.

Comply with the United Nations Sustainable Development Goals.

Comply with the European Union Green Deal.

Promote One Health for all.

Promote science-driven regulations.
To require data sharing across sectors by increasing transparency and open access to information on the production and distribution of antiparasitic drugs of human and animal use (industry production, distribution, prescription).
Set up regular and compulsory control programmes for monitoring the environmental impact of drugs for PVBD in the water and soil, and their safety for vegetation, microbes and aquatic organisms.